Our Methodology

1. How We Build Our Guides

Transparency note: Trouvera guides are produced using AI-assisted research synthesis with human editorial review. Large language models are used to aggregate, organize, and translate primary medical literature into structured guide drafts. Every draft then undergoes human editorial review and our proprietary multi-perspective verification process (described below) before publication.

Evidence Hierarchy

We do not rely on press releases, blog posts, or secondhand summaries. Every guide draws from primary medical literature, organized by evidentiary weight:

We explicitly exclude: social media posts, manufacturer marketing materials, anecdotal testimonials, and non-peer-reviewed preprints (unless specifically labeled as preliminary).

2. How We Verify for Accuracy

The single most important question about any medical information resource is: how do you know it’s correct? Traditional editorial review relies on individual experts catching errors through careful reading. We supplement that approach with something more systematic.

What This Catches

In validation testing across 15 published guides, this methodology identified and corrected the following errors — errors that would have reached patients under a single-source production model:

Fifteen errors across 15 guides may sound modest, but consider that each one — a phantom clinical trial, a wrong approval status, a mischaracterized drug interaction — could mislead a patient or their physician. Our verification process exists to catch these before they reach you.

3. Computational Pharmacology Integration

Trouvera guides are enhanced by proprietary computational pharmacology engines that simulate biological processes to validate and extend the clinical evidence base. These capabilities allow us to cross-reference clinical findings against computational models, adding an additional layer of analytical depth beyond what literature review alone provides.

4. Platform Roadmap

Trouvera is not a static collection of documents. We are building toward a comprehensive, interactive medical research platform. The following capabilities are in various stages of development:

5. Editorial Standards

Our guides follow strict editorial principles aligned with established frameworks for health information quality:

• No treatment recommendations. We describe options and evidence — we never tell a patient what to choose. Every guide emphasizes that decisions must be made with the patient’s medical team.
• Standard care first. Complementary options, clinical trials, and lifestyle measures are always presented as additions to standard evidence-based treatment, never replacements.
• Absolute numbers over relative numbers. When reporting trial results, we prefer absolute benefit over relative measures, so readers can judge magnitude of effect themselves.
• Named trials. Key results cite the specific trial by name so readers and their doctors can verify the data independently.
• Safety warnings. Every guide includes prominent safety warnings for symptoms requiring emergency attention, and warns against stopping or changing treatment without medical guidance.
• No commercial influence. Trouvera accepts no pharmaceutical advertising, sponsorship, or referral fees. Guides are funded entirely by the organization.
• Uncertainty acknowledged. Every guide includes honest assessment of areas where the evidence is incomplete, conflicting, or evolving.

6. Feedback & Error Reporting

The best medical information resources are living documents that improve through feedback. We take every correction request seriously and have built structured processes to handle them:

How feedback is handled:

• All feedback enters a moderated queue reviewed weekly by our editorial team.
• Reported errors are verified through the same patent-pending multi-perspective verification process used in initial guide production — corrections are held to the same evidentiary standard as original content.
• Verified corrections are published with attribution (if desired) and documented in the guide’s Update Log.
• Community contributions are reviewed and validated before appearing publicly — we do not publish unverified user-submitted medical claims.

7. Conflict of Interest & Funding

Trouvera is independently funded. We accept no pharmaceutical advertising, sponsorship, referral fees, or affiliate revenue from any entity whose products or services are discussed in our guides.

Contributor Disclosure Policy

All contributors and future advisory board members are required to disclose financial and professional conflicts of interest, including:

• Consulting fees, speaking fees, or research funding from pharmaceutical or device companies
• Stock ownership or advisory board membership in companies whose products are discussed in the guides
• Employment by entities with a financial interest in the conditions covered

Disclosures will be posted alongside reviewer names when the Expert Review Board is established. Guides covering products from a disclosed company will note the relationship at the top of the guide. This policy follows the ICMJE conflict-of-interest disclosure framework.

Last editorial process review: May 2026. Next scheduled: November 2026.

8. What We Are Not

Transparency requires saying clearly what Trouvera does not do:

• We are not a medical provider. Our content does not create a doctor-patient relationship.
• We do not practice medicine in any state or jurisdiction.
• We do not currently have an Expert Review Board providing formal clinical sign-off. This is a known gap we are actively addressing through recruitment (see Roadmap above).
• Our guides are produced using AI-assisted research synthesis with human editorial oversight and patent-pending multi-perspective verification. We disclose this because we believe transparency about production methods is essential for trust.
• We are not yet externally certified. The HONcode certification program has been discontinued. We are pursuing PIF TICK (Patient Information Forum) and URAC health content certification as current, recognized quality benchmarks. Application has been submitted.
• We do not guarantee completeness. Despite best efforts, no guide can cover every nuance of a complex medical condition.

9. Intellectual Property

All Trouvera guides, including their selection, arrangement, organization, and editorial presentation of medical information, are original works of authorship protected by United States and international copyright law.

Our research synthesis methodology, multi-perspective verification system, source selection processes, computational pharmacology integration, and production pipeline are proprietary trade secrets and patent-pending intellectual property of Trouvera (US Provisional Patent Application filed 2026). The verification methodology described on this page is the subject of an active patent application; the specific architecture, algorithms, and implementation details are confidential.

Reproduction, redistribution, or use of our content for AI/ML training purposes is prohibited without written consent. See our Terms of Use for details.